Drugs / cardiotrophin-1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01334697 | Nov 2012 → Aug 2013 | — | Digna Biotech S.L. | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | cardiotrophin-1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01334697 ↗ |
| Known as | CT-1 | “Cardiotrophin-1 (CT-1)in Healthy Volunteers” NCT01334697 ↗ |
| Modality | Protein / enzyme biologic | “recombinant human cardiotrophin-1” NCT01334697 ↗ |
| Route | Intravenous | “Single dose intravenous administration” NCT01334697 ↗ |